| These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007 | CSL Behring AG | CSL Behring (Australia) Pty Ltd | 20260504 | 29 |
| These highlights do not include all the information needed to use ASCENIV ™ safely and effectively. See full prescribing information for ASCENIV. ASCENIV (immune globulin intravenous, human – slra) 10% Liquid Initial U.S. Approval: 2019 | ADMA Biologics, Inc. | ADMA Biologics, Inc | 20260430 | 12 |
| These highlights do not include all the information needed to use GAMUNEX-C FlexBag safely and effectively. See full prescribing information for GAMUNEX-C FlexBag. GAMUNEX-C FlexBag, [immune globulin injection (human), 10%, caprylate/chromatography purified] for intravenous use. Initial U.S. Approval: 2003 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | GRIFOLS BIOLOGICALS LLC | 20260430 | 3 |
| These highlights do not include all the information needed to use YIMMUGO safely and effectively. See full prescribing information for YIMMUGO. YIMMUGO (immune globulin intravenous, human - dira), 10% liquid Initial U.S. Approval: 2024 | Biotest AG | 20260301 | 6 |
| These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 2014 | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | Catalent Indiana, LLC | Takeda Manufacturing Austria AG | Baxalta US Inc. | 20260204 | 22 |
| These highlights do not include all the information needed to use GAMMAGARD LIQUID ® safely and effectively. See full prescribing information for GAMMAGARD LIQUID. GAMMAGARD LIQUID ® , Immune Globulin Infusion (Human), 10% Solution, for intravenous and subcutaneous administration Initial U.S. Approval: 2005 | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | Baxalta US Inc. | 20251210 | 22 |
| These highlights do not include all the information needed to use QIVIGY safely and effectively. See full prescribing information for QIVIGY. QIVIGY (immune globulin intravenous, human-kthm) 10% solution Initial U.S. Approval: 2025 | Kedrion S.p.A. | 20251201 | 4 |
| These highlights do not include all the information needed to use CUVITRU ® safely and effectively. See full prescribing information for CUVITRU. CUVITRU ® , Immune Globulin Subcutaneous (Human), 20% Solution Initial U.S. Approval: 2016 | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | 20251125 | 19 |
| These highlights do not include all the information needed to use GAMMAGARD S/D safely and effectively. See full prescribing information for GAMMAGARD S/D GAMMAGARD ® S/D, Immune Globulin Intravenous (Human) IgA less than 1 microgram per mL in a 5% Solution Initial U.S. Approval: 1994 | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | Baxter Healthcare Corporation | Siegfried Hameln GmbH | 20251125 | 12 |
| These highlights do not include all the information needed to use FLEBOGAMMA 5% DIF safely and effectively. See full prescribing information for FLEBOGAMMA 5% DIF. FLEBOGAMMA 5% DIF (immune globulin intravenous [human]), solution for intravenous administration Initial U.S. Approval: 2006 | GRIFOLS USA, LLC | Instituto Grifols, S.A. | GRIFOLS WORLDWIDE OPERATIONS LIMITED | 20251117 | 34 |
| These highlights do not include all the information needed to use GAMMAGARD LIQUID ® ERC safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)] 10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025 | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | 20251030 | 2 |
| These highlights do not include all the information needed to use GAMMAPLEX ® 10% safely and effectively. See full prescribing information for GAMMAPLEX 10%. GAMMAPLEX 10% Immune Globulin Intravenous [Human], 10% Liquid Initial U.S. Approval: 2017 | Bio Products Laboratory Ltd | 20251023 | 16 |
| These highlights do not include all the information needed to use GAMMAPLEX 5% ® safely and effectively. See full prescribing information for GAMMAPLEX 5% ® . GAMMAPLEX 5% Immune Globulin Intravenous (Human), 5% Liquid, for intravenous use Initial U.S. Approval: 2009 | Bio Products Laboratory Limited | 20250916 | 26 |
| These highlights do not include all the information needed to use ALYGLO safely and effectively. See full prescribing information for ALYGLO . ALYGLO (immune globulin intravenous, human- stwk ) , 10% Liquid Initial U.S. Approval: 20 2 3 | GC Biopharma Corp. | GC Biopharma Corp_Ochang Plant | 20250611 | 4 |
| These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | Octapharma USA Inc | 20250508 | 2 |
| These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | Pfizer Laboratories Div Pfizer Inc | 20250508 | 10 |
| These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | ADMA Biologics, Inc. | 20250505 | 15 |
| These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 | Pfizer Laboratories Div Pfizer Inc | 20250324 | 15 |
| These highlights do not include all the information needed to use XEMBIFY safely and effectively. See full prescribing information for XEMBIFY. XEMBIFY (immune globulin subcutaneous, human – klhw) 20% solution Initial U.S. Approval: 2019 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | 20250317 | 12 |
| These highlights do not include all the information needed to use GAMASTAN safely and effectively. See full prescribing information for GAMASTAN. GAMASTAN[immune globulin (human)], solution for intramuscular injection Initial U.S. Approval: 1944 | GRIFOLS USA, LLC | Grifols Therapeutics LLC | 20240920 | 36 |
| These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam. Octagam [Immune Globulin Intravenous (Human)] 5% Liquid Preparation Initial U.S. Approval: 2004 | Pfizer Laboratories Div Pfizer Inc | 20240129 | 3 |
| These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | Pfizer Laboratories Div Pfizer Inc | 20240126 | 2 |
| These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 2010 | CSL Behring AG | 20230420 | 26 |
| 82462-103 IYPOLY | Whoniz | 20220601 | 2 |
| These highlights do not include all the information needed to use GAMUNEX ® -C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX ® -C, [Immune Globulin Injection (Human), 10% Caprylate/Chromatography Purified] Initial U.S. Approval: 2003 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | GRIFOLS BIOLOGICALS LLC | 20220429 | 37 |
| These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam. Octagam [Immune Globulin Intravenous (Human)] 5% Liquid Preparation Initial U.S. Approval: 2004 | Octapharma USA Inc | 20220419 | 11 |
| These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 2014 | Octapharma USA Inc | 20220408 | 21 |
| These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 | Octapharma USA Inc | 20211130 | 13 |
| These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | Octapharma USA Inc | 20210215 | 11 |
| These highlights do not include all the information needed to use GAMMAKED™ safely and effectively. See full prescribing information for GAMMAKED. GAMMAKED™, [Immune Globulin Injection (Human), 10% Caprylate/ Chromatography Purified] Initial U.S. Approval: 2003 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | 20200114 | 34 |
| These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | KEDRION BIOPHARMA, INC. | Biotest Pharmaceuticals Corporation | 20160225 | 2 |
| Octagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam. | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 20090909 | 4 |
| Octagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam. | Octapharma AB | 20090909 | 1 |